greeksoup/ stock research
Stock research / United States / KRSA / Documents

Korsana Biosciences, Inc. documents

Korsana Biosciences (KRSA) annual report: the 10-K filed 30 March 2026 for the year ended 31 December 2025. Proxy statement (DEF 14A) filed 15 October 2026; latest 10-Q filed 4 August 2026 for the quarter ended 30 June 2026. Each links to the document on EDGAR, with 1 earnings press release.

Earnings press releases (exhibit 99 to each results 8-K)

FiledDocumentOpenWhere
11 September 2026Results press release, exhibit 99 to the 8-K filed 11 September 2026The releaseEDGAR folder

Annual reports (10-K)

FiledDocumentOpenWhere
30 April 202610-K/A, period ended 31 December 2025The documentEDGAR folder
30 March 202610-K, period ended 31 December 2025The documentEDGAR folder
12 November 202510-K/A, period ended 31 December 2024The documentEDGAR folder

Quarterly reports (10-Q)

FiledDocumentOpenWhere
4 August 202610-Q, period ended 30 June 2026The documentEDGAR folder
12 May 202610-Q, period ended 31 March 2026The documentEDGAR folder
12 November 202510-Q, period ended 30 September 2025The documentEDGAR folder

Proxy statements

FiledDocumentOpenWhere
15 October 2026DEF 14A, period ended 13 November 2026The documentEDGAR folder